Sequence Similarity Clusters for the Entities in PDB 3W12

Entity #1 | Chains: E
Insulin receptor domains L1-CR protein, length: 310 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 7 12581
95 % 7 7 12122 Flexibility: Low
Max RMSD: 1.4, Avg RMSD: 0.8
PDBFlex
90 % 7 7 11937
70 % 7 7 11255
50 % 7 7 10107
40 % 7 7 9127
30 % 7 7 7721
Entity #2 | Chains: C
monoclonal antibody fab 83-7 fragment - heavy chain protein, length: 116 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 18241
95 % 5 5 16891 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 5 5 16506
70 % 65 78 585
50 % 620 712 6
40 % 5962 6382 1
30 % 7383 7934 1
Entity #3 | Chains: D
monoclonal antibody fab 83-7 fragment - light chain protein, length: 114 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 18011
95 % 5 5 16677 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 6 9 8212
70 % 188 236 71
50 % 293 367 18
40 % 337 411 28
30 % 7384 7934 1
Entity #4 | Chains: A
Insulin A chain protein, length: 21 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 227 295 7
95 % 228 301 10 Flexibility: Low
Max RMSD: 6.8, Avg RMSD: 1.0
PDBFlex
90 % 229 303 11
70 % 233 309 13
50 % 233 309 19
40 % 233 309 33
30 % 233 309 54
Entity #5 | Chains: B
Insulin B chain protein, length: 26 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 221 271 8
95 % 234 308 9
90 % 234 308 10
70 % 234 311 15
50 % 234 311 21
40 % 234 311 35
30 % 234 311 57
Entity #6 | Chains: F
Insulin receptor alpha-CT peptide protein, length: 16 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
3 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
4 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
5 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
6 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
7 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
8 5L6Q 1 A, B H5AL 9606
9 5C2B 2 L 3B4 light chain 9606
10 3T0W 1 A, B immunoglobulin variable lambda domain 9606
11 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
12 3T0V 1 A immunoglobulin variable lambda domain 9606
13 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
14 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
15 1SQ2 2 N novel antigen receptor 7801
16 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
17 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
18 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
19 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
20 3CDC 1 A, B Light Chain Amyloidogenic 9606
21 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
22 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
23 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
24 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
25 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
26 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
27 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
28 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
29 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
30 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
31 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
32 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
33 5IR3 1 A Ig lambda chain V-VI region AR 9606
34 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
35 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
36 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
37 5L8L 2 B New antigen receptor variable domain 168098
38 4AIZ 1 A, C, D V2-17 PROTEIN 9606
39 4AIZ 2 B V2-17 PROTEIN 9606
40 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
41 4L1H 1 A Ig kappa chain V-I region Rei 9606
42 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
43 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
44 3BD3 1 A, B catalytic antibody 10090
45 2OTU 1 A, C, E, G Fv light chain variable domain 10090
46 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
47 5L8J 2 B New antigen receptor variable domain 168098
48 1T6V 2 N, O novel antigen receptor 7801
49 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
50 4N1C 1 A, B immunoglobulin variable light chain domain 9606
51 6J5D 3 L antibody light chain 10090
52 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
53 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
54 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
55 6J5F 3 L antibody light chain 10090
56 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
57 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
58 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
59 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
60 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
61 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
62 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
63 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
64 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
65 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
66 5L8K 2 B New antigen receptor variable domain 168098
67 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
68 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
69 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
70 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
71 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
72 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
73 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
74 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
75 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
76 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
77 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
78 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
79 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
80 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
81 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
82 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
83 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
84 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
85 6BAN 1 A, C, E, G Variable domain of R11 Light Chain 9606
86 5C9K 1 A, B, C, D, E, F, G, H Amyloid lambda 6 light chain variable region PIP 9606
87 1FGV 1 L H52 FV (LIGHT CHAIN) 9606
88 4LCI 1 L anti canine CD28 antibody, 1C6, light chain 10090
89 1A7N 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
90 1CD0 1 A, B PROTEIN (JTO, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) IMMUNOGLOBULIN VARIABLE DOMAIN 9606
91 4LRN 2 L GEP 1 light chain 9606
92 1EK3 1 A, B KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL, REC 9606
93 2YC1 2 B, E SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN 9606
94 1G7H 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
95 1A7O 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
96 1KIR 1 A MONOCLONAL ANTIBODY D1.3 10090
97 2DQE 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
98 1DVF 1 A FV D1.3 IGG1, KAPPA 10090
99 1DVF 3 C FV E5.2 IGG1, KAPPA 10090
100 1G7M 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
101 1OAU 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
102 1B0W 1 A, B, C BENCE-JONES KAPPA I PROTEIN BRE VARIABLE DOMAIN OF LIGHT CHAIN 9606
103 1A6W 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
104 1A7R 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
105 1WZ1 1 L Ig light chain 10090
106 3UPA 1 A, B kappa light chain variable domain 9606
107 3LVE 1 A LEN KAPPA-IV LIGHT CHAIN DIMER 9606
108 1A7P 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
109 4K3G 1 A, B immunoglobulin lambda variable domain L5(L89S) 9606
110 1XIW 3 C, G immunoglobulin light chain variable region 10090
111 5NGV 3 L anti-human ActRIIB mAb BYM338 light-chain VL 9606
112 1A7Q 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
113 1DSF 1 L ANTICANCER ANTIBODY B1 FV 10090
114 3DUU 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
115 3BJ9 1 1 Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1 Fusion protein consists of Ig domain of VPREB protein and J-fragment of Ig lambda-5 9606
116 1H5B 1 A MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
117 1H5B 2 B, D MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
118 1H5B 3 C MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
119 3LRG 1 A, B anti-huntingtin VL domain anti-huntingtin VL domain 9606
120 1KIP 1 A MONOCLONAL ANTIBODY D1.3 10090
121 6A3W 2 B, E, H, K utomilumab VL 9606
122 5LVE 1 A BENCE-JONES PROTEIN LEN G KAPPA CHAIN V-IV, VARIABLE DOMAIN, LIGHT CHAIN 9606
123 2EIZ 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
124 1PW3 1 A, B immunoglobulin lambda chain variable region 9606
125 5JPJ 1 A, B 6aJL2 protein 9606
126 2UZI 2 L ANTI-RAS FV LIGHT CHAIN 9606
127 2I27 1 N, O New Antigen Receptor Ancestral variable domain 7801
128 3T0X 1 A, B Immunoglobulin variable lambda domain M8VLA4(S55P) 9606
129 1UA6 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
130 1IC7 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
131 1CFV 1 L MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
132 1QP1 1 A, B, C BENCE-JONES KAPPA I ANTIBODY BRE (LIGHT CHAIN) IMMUNOGLOBULIN FRAGMENT, VARIABLE DOMAIN 9606
133 3U7A 1 A Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain 9606
134 4UU9 2 B, L MEDI7814 VARIABLE DOMAIN LIGHT CHAIN 9606
135 3MOQ 1 A, B, C, D New antigen receptor variable domain,P3(40) peptide from Amyloid beta A4 protein,New antigen receptor variable domain CHIMERA OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN (RESIDUES 1-87 AND 102-113 FROM UNP Q6X1E6) INSERTED WITH AMYLOID BETA 18-41 (RESIDUES 689-712 FROM UNP P05067) 168098
136 1G7L 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
137 1BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
138 1IVL 1 A, B IGG-KAPPA M29B FV (LIGHT CHAIN) 10090
139 1A6U 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
140 2DQI 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
141 1BRE 1 A, B, C, D, E, F BENCE-JONES KAPPA I PROTEIN BRE 9606
142 3CX5 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
143 5B8C 1 A, D, G, J Pembrolizumab light chain variable region (PemVL) 9606
144 3DV6 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
145 1VES 1 A, B New Antigen Receptor variable domain 168098
146 2EKS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
147 3BD5 1 A, B catalytic antibody 10090
148 4XVJ 3 L antibody light chain variable domain 9606
149 1AC6 1 A, B T-CELL RECEPTOR ALPHA VARIABLE DOMAIN 10090
150 1JV5 1 A Ig kappa chain precursor V region anti-blood group A Fv 9606
151 1FVC 1 A, C IGG1-KAPPA 4D5 FV (LIGHT CHAIN) 9606
152 4Z0X 1 A Antibody HC26AM light chain variable domain 9606
153 1IC5 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
154 2CD0 1 A, B PROTEIN (BENCE-JONES PROTEIN WIL, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) VARIABLE DOMAIN 9606
155 4LAS 2 L Single light chain Variable fragment Light Chain 10090
156 2A9M 1 L, M fluorescein-scfv light chain 9606
157 2YWZ 1 A new antigen receptor variable domain 168098
158 1A6V 1 L, M, N B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
159 3DUS 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
160 5NH3 3 L, M anti-human ActRIIB mAb BYM338 Fv light-chain 9606
161 2COQ 1 A new antigen receptor variable domain 168098
162 5GRV 2 K homo-specific diabody light chain 9606
163 2GSG 1 A, C monoclonal antibody light chain variable domain 10090
164 2W0L 1 A, B, C, D V1-22 protein 9606
165 5TBD 2 B, F, G, K Fv fragment (mAb4D1) heavy chain 10090
166 5DHV 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
167 4LVE 1 A, B LEN KAPPA-IV LIGHT CHAIN DIMER 9606
168 43C9 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
169 1NMB 2 L FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
170 1I8I 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
171 1OAR 2 L, M, N, O IMMUNOGLOBULING E FV, RESIDUES 1-110 10090
172 1D9K 1 A, E T-CELL RECEPTOR D10 (ALPHA CHAIN) 10090
173 3DV4 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
174 6A78 2 L, M Light chain region of the anti-human Robo1 antibody B5209B scFv 10090
175 1I3G 1 L ANTIBODY FV FRAGMENT VL DOMAIN 10090
176 1DL7 1 L PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN)) COMBINED LIGHT AND HEAVY CHAIN VIA (G4S)3 LINKER FV (SINGLE CHAIN) 10090
177 1OCW 2 L IMMUNOGLOBULIN E FV REGION, RESIDUES 1-120 10090
178 1IGM 1 L IGM-KAPPA POT FV (LIGHT CHAIN) 9606
179 5GS1 1 A, M, O, Q light chain 9606
180 2DQG 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
181 2PXY 1 A T cell receptor alpha chain 10090
182 3BDX 1 A, B, C Amyloid lambda 6 light chain variable region PIP (fragment) Residues 1-111 9606
183 43CA 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
184 2DQH 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
185 2Q1E 1 A, B, C, D Amyloidogenic immunoglobulin light chain protein AL-09 9606
186 3EHB 4 D FV fragment Chain L 10090
187 3HB3 4 D ANTIBODY FV FRAGMENT 10090
188 4FFY 1 L DENV1-E111 single chain variable fragment (light chain) 10090
189 4N1E 1 A, B, C, D, E, F, G, H immunoglobulin variable light chain domain 9606
190 5LBS 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 SCFV fragment, light chain 9606
191 1AP2 1 A, C MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
192 1IC4 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
193 3CDY 1 A, B IMMUNOGLOBULIN LIGHT CHAIN 9606
194 4RAV 1 B, D Single-chain Fv, VL 9606
195 5XJ4 3 L durvalumab-VL 9606
196 5LWY 3 L V REGION LIGHT CHAIN 10090
197 1KB9 11 K LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
198 4X4X 2 B, D Human Variable Light Chain of Herceptin 9606
199 2Z8V 2 C, D New antigen receptor variable domain 168098
200 2W0K 1 A, B V1-22 PROTEIN 9606
201 2BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
202 2IBZ 11 Y Variable Light chain of antibody fragment 10090
203 4K3H 1 A, B, C, D, E, F, G, H Immunoglobulin lambda variable domain L5(L89S) 9606
204 2Z8W 2 C, D New antigen receptor variable domain 168098
205 2OI9 2 B T cell receptor alpha chain 10090
206 4HGM 1 A Shark V-NAR 7797
207 3BD4 1 A, B catalytic antibody 10090
208 1WT5 2 C, D ANTI EGFR ANTIBODY FV REGION VL fragment 9606
209 1JHL 1 L IGG1-KAPPA D11.15 FV (LIGHT CHAIN) 10090
210 4LLV 2 B, D, F, L 4E10 Fv light chain 9606
211 4LAR 2 L Single light chain variable fragment Light Chain 10090
212 5CBA 2 B, D 3b4 light chain 9606
213 1A14 3 L NC10 FV (LIGHT CHAIN) VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
214 1C08 1 A ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VL FRAGMENT 10090
215 2OTW 1 A, C Fv light chain avriable domain VL 10090
216 2YSS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
217 2YBR 2 B, E, H SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN, RESIDUES 118-263 9606
218 2I26 1 N, O, P New Antigen Receptor Ancestral variable domain 7801
219 2BJM 2 L IGE SPE7 LIGHT CHAIN LIGHT CHAIN, RESIDUES 1-110 10090
220 1P4B 1 L Antibody Variable light chain 10090
221 4Y5V 2 B, E, H Diabody 305 VL domain 9606
222 1I9E 1 A CYTOTOXIC TCELL VALPHA DOMAIN N-TERMINAL DOMAIN OF ALPHA CHAIN 10090
223 1DQL 1 L IGM MEZ IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN FRAGMENT 9606
224 6MTJ 3 E 35O22 scFv light chain portion 9606
225 2Z35 1 A T-cell receptor alpha-chain 10090
226 4X4Y 2 B, D Human Variable Light Chain of Herceptin 9606
227 1VER 1 A New Antigen Receptor variable domain 168098
228 4YQX 2 L, O JES6-1 VL domain 10116
229 1FO0 4 A PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
230 1EZV 11 Y LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
231 3U6R 2 B, L Antibody 1:7 (Light chain) 9606
232 1U3H 1 A, E T-cell receptor alpha-chain V2.3-J39-C 10090
233 2YWY 1 A, B, C, D new antigen receptor variable domain 168098
234 1NMC 3 C, L SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
235 1KB5 1 A KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
236 2DQF 1 A, D lysozyme binding Ig kappa chain V23-J2 region 10090
237 1B88 1 A, B T CELL RECEPTOR V-ALPHA DOMAIN V-ALPHA DOMAIN 10090
238 6MTN 3 E 35O22 scFv light chain portion 9606
239 3CXH 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
240 6MU7 3 E 35O22 scFv light chain portion 9606
241 2E7L 1 A, B Cytotoxic Tcell receptor UNP RESIDUES 21-132 10090
242 5YOY 2 D, E, F, M, N, O Golimumab light chain variable region 9606
243 2ICW 5 I, K T-cell receptor alpha chain V residues 21-131 10090
244 1P84 11 K Light Chain (Vl) Of Fv-Fragment 10090
245 2XTJ 2 B FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
246 5CBE 2 B, D E10 light chain 9606
247 3WXW 3 L V region light chain 10090
248 1F6L 1 L ANTI-FERRITIN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE LIGHT CHAIN 9606
249 3LRH 1 A, C, E, G, I, K, M, O anti-huntingtin VL domain anti-huntingtin VL domain 9606
250 1AR1 4 D ANTIBODY FV FRAGMENT 10090
251 1BVK 1 A, D HULYS11 FV 9606
252 5FV1 1 L, M VK DOMAIN ANTIBODY VK DOMAIN ANTIBODY, RESIDUES 1-108 9606
253 6MU6 3 E 35O22 scFv light chain portion 9606
254 6A79 2 L, M Light chain region of the anti-human Robo1 antibody B5209B scFv 10090
255 2CJU 2 L NQ16-113.8 ANTI-PHOX ANTIBODY 10090
256 1P4I 1 L ANTIBODY VARIABLE LIGHT CHAIN 10090
257 2LVE 1 A RLEN KAPPA-IV LIGHT CHAIN DIMER 9606
258 2VH5 2 L ANTI-RAS FV LIGHT CHAIN 9606
259 3LH2 3 L, M, N, O Fv 4E10 light chain 9606
260 1OAZ 3 L, N IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
261 1KJ2 4 A, D KB5-C20 T-Cell receptor alpha-chain Fv fragment , variable domain 10090
262 1OAY 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
263 4LAQ 2 L Single light chain variable fragment Light Chain 10090
264 5LXG 3 L V REGION LIGHT CHAIN 10090
265 4RZC 2 B, D, F, L Fv M6P-1 heavy chain 9986
266 3H3P 2 L, M Fv 4E10 light chain 9606
267 3NN8 2 B, E, F, H Engineered scFv, light chain 10090
268 1OAX 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
269 4V1D 2 B SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN 9606
270 4V1D 5 E SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN 9606
271 2Z31 1 A T-cell receptor alpha-chain 10090
272 6H3T 2 L, M scFv 1C11 VL 10090
273 6NNJ 3 E 35O22 scFv light chain 9606
274 6NNJ 8 V CH31 scFv light chain 9606
275 1NMA 2 L FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
276 1NAM 1 A BM3.3 T Cell Receptor alpha-Chain Fv Fragment, Variable Domain 10090
277 4Y5Y 2 B, E diabody 330 VL domain 9606
278 1BVL 2 B, D HULYS11 FV 10090
279 6CF2 2 B Anti-Rev Antibody, light chain Fab single-chain variable fragment 9986
280 4UNT 1 A, B, C, D, E, F, G, H IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
281 3AB0 3 C, F antibody ScFv fragment, light chain 10090
282 3LHP 2 L, M Fv 4E10 light chain 9606
283 6NM6 3 E 35O22 scFv light chain 9606
284 6NM6 8 V N6 FR3-03 light chain 9606
285 2BX5 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O VD9 VKI LIGHT-CHAIN LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
286 6CK9 3 E 35O22 scFv light chain portion 9606
287 6NNF 3 E 35O22 scFv light chain 9606
288 6NNF 8 V VRC01 FR3-03 light chain 9606
289 2UUD 2 K, L NQ10-1.12 ANTI-PHOX ANTIBODY 10090
290 4Y5X 2 B, E, H, K diabody 310 VH domain 9606
291 6H3U 2 L, M scFv 4B6 VL 10090
292 6MU8 3 E 35O22 scFv light chain portion 9606
293 4UT9 3 L, M, N, O BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, LIGHT CHAIN DOMAIN 9606
294 2A9N 1 L, M fluorescein-scfv light chain 9606
295 5XQY 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 Y96K mutant of REI VL 9606
296 5GS0 2 C, E light chain (anti-TLR3) 10090
297 5GS0 5 L, Y light chain (anti-Lid) 10090
298 5YY5 3 L Light chain 9606
299 5YY5 5 D Light chain 9606
300 1KYO 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT RESIDUES 1-107 10090
301 5GRJ 2 L avelumab L chain 9606
302 4NKD 2 B, D, F, H Engineered scFv light chain 10090
303 6MUG 3 E 35O22 scFv light chain portion 9606
304 6IW2 3 C, F, I, L, O, R Light chain of monoclonal antibody 5A 9606
305 3WXV 3 L V region light chain 10090
306 1AR2 1 A REI VARIABLE REGION, LIGHT CHAIN 9606
307 4KV5 3 F, I, K, L light chain GC1009 scFv 9606
308 1QLE 6 L LIGHT CHAIN ANTIBODY FV FRAGMENT 10090
309 6J5G 3 L antibody light chain 10090
310 3E3Q 3 C, D, I, M, R, V, Z, d T-cell receptor alpha chain V region PHDS58 10090
311 6MUF 3 E 35O22 scFv light chain portion 9606
312 5XP1 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 UNP residues 22-117 9606
313 5XJ3 2 B, E, H, K ipilimumab-VL 9606
314 4M8Q 2 B, L GEP1 Fv light chain UNP residues 21-129 9606
315 5NHR 1 B, L Bimagrumab Fv Light-Chain VL domain LIGAND BINDING domain 9606
316 5J3H 3 D mAb 83-7 Fab light chain 10090
317 5U8R 3 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
318 5XWD 3 D VL chain of 059-152 9606
319 4YBQ 2 C, E antibody Fv fragment light chain 10090
320 4PD4 11 K Ig kappa chain V-V region HP 124E1 10090
321 4R0L 3 B, L Antibody 1C6 Light chain UNP residues 20-137 10090
322 5U8Q 4 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
323 4ODX 3 B, L GEP7 Fv light chain 9606
324 3E2H 3 B T-cell receptor alpha chain V region PHDS58 10090
325 4H1L 4 G, I Ani2.3 TCR A chain 562
326 1RVF 5 L FAB 17-IA 10090
327 5JZ7 3 D, I, K, L MEDI578 scFv, light chain 9606
328 5DHY 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
329 1QFW 3 L ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN) FV 10090
330 1QFW 5 M ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN) FV 10090
331 4OGA 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
332 4NKM 2 B, D, F, H Engineered scFv light chain 10090
333 6IW0 3 L Light chain of monoclonal antibody 5A 9606
334 3W11 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
335 4NKO 1 A, C, E Engineered scFv light chain 10090
336 3W13 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
337 3W12 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
338 5DHZ 2 L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
339 2A0L 2 C, E 33H1 Fv fragment Fv fragment,light chain 10090
340 5WDU 3 E, P, X bnAb NIH45-46 scFv light chain 9606
341 6NN3 3 L Fab monoclonal antibody 860-55D, light chain 9606
342 6NB3 2 E, L LCA60 light chain 9606
343 6NB4 3 L LCA60 light chain 9606
344 6NB6 3 L, M S230 light chain 9606
345 6NB7 3 E, I, L S230 light chain 9606
346 6MID 4 L monoclonal antibody ZIKV-195 light chain Fab variable domain 9606
347 6IDI 4 J, L, N Fab 1H10 light chain (V-region) 9606
348 6IDK 4 J, L, N Fab 1H10 light chain (V-region) 9606
349 6IDL 4 J, N Fab 1H10 light chain (V-region) 9606
350 6AJ7 1 L VL of Fab 15C5 10090
351 6AJ9 1 E VL of Fab 11G1 10090
352 6AJ9 3 L VL of Fab 15C5 10090
353 6AD0 1 L VL of Fab 2G8 10090
354 6DZL 3 J, K, L Fv domain of ADI-15878 Fab light chain 9606
355 6DZM 3 H, K, L Antibody ADI-15878 Fab, light chain 9606
356 6GV4 6 L AT12-015 antibody variable light polypeptide chain 9606
357 6GG0 3 L light chain 9606
358 6CUE 4 4, L, l vFP7.04 light chain 10090
359 6CUE 6 6, N, n PGT122 Light chain 9606
360 6CUE 8 8, R, r VRC03 light chain 9606
361 6CUF 4 6, N, n PGT122 light chain 9606
362 6CUF 5 7, R, r VRC03 light chain 9606
363 6CDI 3 6, N, n PGT122 Light Chain 9606
364 6CDI 5 7, R, r VRC03 light chain 9606
365 6BSP 2 B U4 Light chain 10090
366 5Y0A 3 E, G, L variable region of Fab ZKA190 light chain 9606
367 5XS7 1 L Light chain of Fab 1D5 10090
368 5W3L 6 G C5 antibody variable light domain 10090
369 5W3M 2 G C5 antibody variable light domain 10090
370 5W3O 2 E C5 antibody variable light domain 10090
371 5W3E 2 G C5 antibody variable light domain 10090
372 5TR1 3 L, M Monoclonal antibody, Fab fragment, light chain 10090
373 5TQQ 2 L, M Monoclonal antibody, Fab fragment, light chain 10090
374 5H32 3 H, L, M C10 IgG light chain variable region 9606
375 5H37 4 H, L, M C10 IgG light chain variable region 9606
376 5H30 4 H, L, M IgG C10 light chain 9606
377 5KEL 4 L, T, U c2G4 variable Fab domain light chain 9606
378 5KEL 6 D, N, O c13C6 variable Fab domain light chain 9606
379 5KEM 1 C, H BDBV91 variable Fab domain light chain 9606
380 5KEM 4 E, J c13C6 variable Fab domain light chain 9606
381 5KEN 4 D, H, O c4G7 variable Fab domain light chain 9606
382 5KEN 5 I, P c13C6 variable Fab domain light chain 9606
383 3JCX 3 L Fab E light chain 10116
384 3JBA 1 L H16.U4 antibody light chain Fab variable domain 10090
385 3JAU 3 L Light chain of Fab fragment variable region of antibody D5 10090
386 5A1Z 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
387 4UIF 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 9606
388 4UIH 3 E, G ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -LIGHT CHAIN 9606
389 4UDF 3 10, 14, 18, 1C, 1G, 1K, 1O, 1S, 1W, 20, 24, 28, 2C, 2G, 2K, 2O, 2S, 2W, 30, 34, 38, 3C, 3G, 3K, 3O, 3S, 3W, 40, 44, 48, 4C, 4G, 4K, 4O, 4S, 4W, 50, 54, 58, 5C, 5G, 5K, 5O, 5S, 5W, 60, 64, 68, 6C, 6G, 6K, 6O, 6S, 6W, 7C, 7G, 7K, 7O, 7S, 7W HUMAN MONOCLONAL ANTIBODY 9606
390 3J8Z 2 J, K, L, M H16.1A light chain variable domain Fab 10090
391 3J8V 2 J, K, L, M H16.14J light chain variable domain Fab 10090
392 3J8W 1 J, K, L, M H263.A2 light chain variable domain Fab 10090
393 3J7E 1 A, C, E, L H16.V5 Fab light chain variable domain 10090
394 3J6U 4 L Fab 5J7 light chain variable region 9606
395 2MMX 1 A V1-22 protein 9606
396 2MKW 1 A V1-22 protein 9606
397 4CKD 3 L, M, N, O SCFV13R4 ANTIBODY FV LIGHT CHAIN 10090
398 2KQM 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
399 2KQN 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
400 3IY1 1 A Fab B, light chain antibody B fragment 10116
401 3IY2 1 A Antibody 6, light chain fragment of antibody 6 10090
402 3IY3 1 A antibody fragment from neutralizing antibody 8 (light chain) FAb 8 10090
403 3IY4 1 A fragment of neutralizing antibody 15 (light chain) fragment of neutralizing antibody 15 10090
404 3IY5 1 A antibody fragment IGG2A (light chain) Fab 10090
405 3IY6 1 A fragment from neutralizing antibody E (light chain) FAb E 10116
406 3IY7 1 A fragment from neutralizing antibody F (light chain) FAb F 10116
407 3IY0 1 L Fab 14, light domain Fab14 10090
408 1QNZ 2 L 0.5B ANTIBODY (LIGHT CHAIN) FV 10090
409 1MAJ 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
410 1MAK 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
411 1REI 1 A, B BENCE-JONES PROTEIN REI (LIGHT CHAIN) 9606